Good MorningEquity markets tried to rebound on Wednesday but could not hold the gain. Rising oil prices invigorated fear of inflation and sent the markets down more than 0.5% at the session's low. The price of WTI advanced more than 3% at its high for the session and is on the verge of breaking out to a new 1-year high. The yield on the 10-year treasury, a gauge of the direction of interest rates, did advance to a new 1-year high, suggesting the FOMC's work is far from over.
Adding to the fear are comments from Fed President Neel Kashkari. In his view, interest rates are not high enough now and could be raised significantly before the threat of inflation is tamed. The S&P 500 could sink another 20% or more in that scenario. The next big hurdle for the market is Friday. The PCE price index is expected to show headline inflation accelerating, which could come hotter than expected. Featured: The World's First "$20 Trillion Drug (Behind the Markets) 
|
Stocks | | |
The markets just went through a relatively peaceful period. For the purpose of this article, I'll define that as a period where the VIX (volatility index) remained below 15 for more than a week. The last time markets enjoyed such a period was right before the shakeups brought on by the COVID-19 pa... Read the Full Story |
|
From Our PartnersYour $300 MarketBeat account credit is expiring in less than 36 hours. Over a thousand of your fellow MarketBeat subscribers have upgraded to MarketBeat All Access Pass this month (and have gotten a great deal on their subscriptions). Unfortunately, you haven't taken action yet. We are making the first month of MarketBeat All Access available for FREE for anyone that registers by 11:59 PM Pacific Time tomorrow night. If you want to continue your subscription after your first month, you'll still receive the $300 discount on your first year's subscription ($99.00 instead of $399.00). | | | | Claim Your Free 30 Day Subscription Here |
|
Stocks | | |
The AI revolution is upon us, and few sectors are better positioned to profit from it than the electronics manufacturing industry. These companies are already leaning hard into AI to improve their operations, increase productivity, and deliver returns for investors, and their clients are doing the... Read the Full Story |
|
Markets | | |
As the old investing adage goes, you should never put all your eggs in one 'basket. This can create immense portfolio risk and lead to devastating losses.
Conversely, spreading wealth into a diversified group of individual stocks, bonds, and alternatives is a more prudent approach — f... Read the Full Story |
|
From Our PartnersWhile Wall Street flounders and giants like Amazon & Microsoft lay off thousands... One overlooked company has been quietly achieving over 400% growth. How? By buying, building, and scaling a portfolio of promising brands in high-margin, recession-resistant verticals. (THIS IS A PAID ADVERTISEMENT) | | | | See Why Investors Are Loving This Company's Business Model for Explosive Growth |
|
Stocks | | |
Whenever a new exciting industry hits the television screens of various market participants, investors crowd around a handful of names, typically those being popularized by talking heads and other quote-unquote professionals.
Today, you will examine why it is better to diversify your exposure acr... Read the Full Story |
|
Stocks | | |
When the prominent investing names on Wall Street decide to move, everyday investors will benefit from keeping an ear to the ground, especially when these positions are broadcasted publicly via mandatory 13-F filings.
Remember that guy who called the 2008 recession Dr. Michael Burry? He just cast... Read the Full Story |
|
From Our PartnersIf you’re looking for an INCREDIBLE deal on stocks with huge growth potential, now is the time to look at this list our team prepared.
(**By clicking the link you are subscribing to the Summa Money Newsletter and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy. Full disclosures found here)
| | Download The List With Details On Each Stock Here |
|
Markets | | | Chase UK, JP Morgan's British digital bank, says it will bar customers from making cryptocurrency transactions starting next month — citing an uptick in scams and fraud.From Oct. 16 onward, Chase customers will no longer be able to make crypto transactions using their debit card or through an outgoi... Read the Full Story |
|
Markets | | | The highest mortgage rates in more than two decades are keeping many prospective homebuyers out of the market and discouraging homeowners who locked in ultra-low rates from listing their home for sale Read the Full Story |
|
Markets | | | JPMorgan Chase agreed Tuesday to pay $75 million to the U.S. Virgin Islands to settle claims that the bank enabled the sex trafficking acts committed by financier Jeffrey Epstein.JPMorgan said that $55 million of the settlement will go toward local charities that provide assistance to victims of dom... Read the Full Story |
|
Markets | | | The confidence of American consumers slipped this month, particularly about the future, as expectations persist that interest rates will remain elevated for an extended period.The Conference Board, a business research group, said Tuesday that its consumer confidence index fell to 103 in September fr... Read the Full Story |
|
Markets | | | The head of the European Central Bank says interest rates will stay high long enough to restrict business activity for “as long as necessary” to beat back inflation because upward pressure on prices “remains strong.” Read the Full Story |
|
Thursday's Early Bird Stock Of The Day Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory. It also provides drugs for hospital use, such as antibiotic, blood clot, personal protective equipment, immunosuppressant, oncology, and analgesics products. In addition, the company offers over-the-counter (OTC) consumer healthcare products through a portfolio on approximately eight therapeutic areas, including gastrointestinal, skin care, cough and cold, analgesics, urological, vitamins, minerals, and supplements in the categories of antibiotics, anti-infective, anti-parasitic, cardiovascular, feminine care, cutaneous antimycotic, pain killers, gastro intestinal, hormonals, metabolic, endocrine, nervous system, ophthalmic, osteoarticular, respiratory, diet supplements, and vitamins and minerals. Further, it provides blood glucose meters, telemonitoring products, oral anti-diabetics products, cosmeceuticals, insulin delivery systems, and other diabetes solutions; and contract drug development and manufacturing services to third party pharmaceutical companies, specializing in soft gelatin capsule technologies. The company was founded in 1977 and is based in Luxembourg, Luxembourg. | | View Today's Stock Pick |
|
